AirICU belongs to the feellife group, a healthcare company centered around treating the upper and lower respiratory tracts of the human body. With the vision of "The Third Way of Dosing" and the technology core of "AiMesh ®" polymer nebulizer, feellife owns more than 250+ international invention patents and certificates, taking the leading position in the field of nebulized drug delivery, and the clinical nebulization equipment for hospital intensive care represented by "AirICU" has already benefited millions of patients in more than 40 countries and regions.
Established respiratory disease care center in the United States.
Raffles Nebulizer Medicine Company was established to focus on the R&D and production of nebulizers with intelligent micro-grid technology.
Create a global atomizing liquid ecological business model of smart atomizer + atomizing liquid.
Create the world's first artificial intelligence atomizer.
Global network atomization ecology and modern traditional Chinese medicine innovation combined.
Global preferred supplier of aerosolized vaccine equipment.
Won the "Global Best Home Atomization Solution Award" from European media.
Received the Annual Global Vaccine Equipment Expert Award from Global Health and Drugs.
MedTech TOP20 innovative medical companies in the United States.
HCA-Hospital Partnership of the Year.
Feellife has been recognized by the medical and product design industry for its technology over the years.
We take pride in responding to your questions and comments
